Renata Guzicka‐Kazimierczak

Central nervous system involvement by multiple myeloma: A multi‐institutional retrospective study of 172 patients in daily clinical practice

Artur Jurczyszyn, Norbert Grząśko, Alessandro Gozzetti et al. · American Journal of Hematology · 2016 · 141 citations · Full text

Medicine, Hematology, Oncology +14

Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients

Artur Jurczyszyn, Jakub Radocha, Julio Dávila et al. · British Journal of Haematology · 2018 · 67 citations · Full text

Medicine, Hematology, Oncology +8

Characteristics and outcomes of patients with multiple myeloma aged 21–40 years versus 41–60 years: a multi‐institutional case‐control study

Artur Jurczyszyn, Hareth Nahi, Irit Avivi et al. · British Journal of Haematology · 2016 · 42 citations · Full text

Medicine, Hematology, Oncology +13

Predictive Model for Infection Risk in Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia Patients Treated With Azacitidine; Azacitidine Infection Risk Model: The Polish Adult Leukemia Group Study

Krzysztof Mądry, Karol Lis, Przemysław Biecek et al. · Clinical Lymphoma Myeloma & Leukemia · 2019 · 20 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

The efficacy and safety of pomalidomide in relapsed/refractory multiple myeloma in a “real‐world” study: Polish Myeloma Group experience

Grzegorz Charliński, Norbert Grząśko, Artur Jurczyszyn et al. · European Journal Of Haematology · 2018 · 18 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15